Metastatic Brain Tumor Collaborative - CNS Metastasis Research Grants

Q: When is the deadline for Metastatic Brain Tumor Collaborative - CNS Metastasis Research Grants?

The funder has not published a deadline for this grant.

American Brain Tumor Association

Foundation Annual Grants for Science Research Grants for Cancer Nonprofits

Funding Amount

$50,000

Deadline

Deadline not published

Grant Type

Foundation

Deadline history & next window

Cycle: Annual
Tracked since: April 2026

Source: the cycle recorded on this listing. Confirm dates with the funder.

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Partner Organizations: This collaborative grant program is made possible through the collective effort of ten leading nonprofit cancer organizations:

Other requirements

Each funded project must address CNS metastases arising from at least two distinct primary cancer types
Research must have potential benefit to adult and/or pediatric populations
Researchers addressing metastatic brain tumors from
Breast cancer

Overview

Duration: One-year seed funding

Purpose: Support high-risk, high-impact projects with the potential to transform how metastatic brain tumors are detected and managed.

Focus Areas:

CNS metastases diagnosis and treatment
Immunotherapy for brain metastases
Tumor biology
Biomarkers of treatment response
Improving diagnosis of metastatic brain tumors

Eligibility Requirements:

Each funded project must address CNS metastases arising from at least two distinct primary cancer types
Research must have potential benefit to adult and/or pediatric populations
Researchers addressing metastatic brain tumors from:
- Breast cancer
- Lung cancer
- Melanoma
- Colorectal cancer
- Kidney cancer
- Other cancer types

Geographic Scope: United States

Background: CNS metastases are the most common type of brain tumor in adults, occurring when cancers spread to the brain or spinal cord. Despite affecting more than 200,000 people in the U.S. each year, this patient population remains vastly underrepresented in research and clinical care.

Partner Organizations: This collaborative grant program is made possible through the collective effort of ten leading nonprofit cancer organizations:

American Brain Tumor Association (Lead)
Kidney Cancer Association
LUNGevity Foundation
Melanoma Research Foundation
Metastatic Breast Cancer Alliance
Aim at Melanoma
Fight Colorectal Cancer
Go2 for Lung Cancer
Living Beyond Breast Cancer
Susan G. Komen
Society for Neuro-Oncology

2025 Recipients:

Sherise Ferguson, MD, The University of Texas MD Anderson Cancer Center - "Evaluating the therapeutic efficacy of NK cell immunotherapy for CNS metastasis"
Alireza Mansouri, MD, PhD, Pennsylvania State University College of Medicine - "Cerebrospinal Fluid Proteomic Signatures of Leptomeningeal Disease"

Contact Information:

American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
Phone: 773-577-8750
Website: abta.org/metastatic-brain-tumor-collaborative

What American Brain Tumor Association actually gave

Source: IRS Form 990, 2025

Grants in 2025: 5
Total given: $187K
Median grant: $30K
Range: $9,000–$100K

By dollars: North Carolina 60%, Texas 19%, Illinois 16%. Top recipient cities: Raleigh, NC; Houston, TX; Hinsdale, IL.
0% of grants with a stated purpose were for general or operating support.

Example grants

Health Research Alliance · Raleigh, NC

Research grant

$100K
Society of Neuro Oncology (Sno) · Houston, TX

Research fellowships

$35K
Central Brain Tumor Registry of the US · Hinsdale, IL

Research grant

$30K
Brain Tumor Epidemiology Consortium (Btec) · Durham, NC

Research grant

$13K
American Association for Cancer Research · Philadelphia, PA

Research grant

$9,000